Actively Recruiting
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Led by Washington State University · Updated on 2024-06-25
205
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.
CONDITIONS
Official Title
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 4 or more standard drinks on the same occasion for women (5 or more for men) on at least 4 occasions in the prior 30 days
- Seeking treatment for alcohol use disorder
- Seeking treatment for smoking cessation
- Aged 18 years or older
- Diagnosed with alcohol use disorder according to DSM-5
- Currently smoking daily (100 or more lifetime cigarettes plus current daily smoking)
- Able to read and speak English
- Able to provide written informed consent
- Breath alcohol level of 0.00 during informed consent
- At least one EtG-positive urine test and one COT-positive urine test during the induction period
- Attended at least 4 of 6 possible visits during the induction period
You will not qualify if you...
- History of alcohol detoxification or seizures in the last 12 months indicating risk of dangerous withdrawal or participant concern about withdrawal
- Currently receiving any pharmacotherapy for alcohol
- Currently receiving any pharmacotherapy for smoking
- Any suicide attempt in the last 20 years
- Any medical or psychiatric condition that would compromise safe participation as determined by study doctors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington State University
Spokane, Washington, United States, 99202
Actively Recruiting
Research Team
A
Abigail Bowen, MS
CONTACT
S
Sterling McPherson, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here